Twist Bioscience Corporation (TWST) FY2026 Q3 P&L / Income Statement

Twist Bioscience Corporation (TWST) FY2026 Q3 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Industry Sectors. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenues

118,376,000 US dollars

Cost of revenues

55,922,000 US dollars

Gross profit (calculated)

62,454,000 US dollars

Operating expenses (calculated)

98,734,000 US dollars

Loss from operations

negative 36,280,000 US dollars

Other income (expense), net (calculated)

1,540,000 US dollars

Income (loss) before income taxes

negative 34,740,000 US dollars

Income tax expense

311,000 US dollars

Net (loss) income

negative 35,051,000 US dollars

Therapeutics

40,413,000 US dollars

Diagnostics

43,843,000 US dollars

Industry and applied

5,749,000 US dollars

Academic research and government

15,512,000 US dollars

Global supply partners

12,859,000 US dollars

Research and development expenses

18,025,000 US dollars

Selling, general and administrative expenses

80,709,000 US dollars

Litigation settlement costs, net of recoveries

0 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.